CALR and rheumatoid arthritis: The study cohort consisted of 670 rheumatoid arthritis (RA) patients divided into two distinct groups based on anti-Ro antibody status: anti-Ro positive (n = 228, 34.03%) and anti-Ro negative (n = 442, 65.97%).